CLINICAL PATHWAYS IN 17 EUROPEAN UNION COUNTRIES: A SURVEY OF EXPERT OPINIONS

  • Don Hindle Medicinska fakulteta na Univerzi New South Wales Avstralija
  • Anne Marie Yazbeck Ministrstvo za zdravje Sektor za razvoj in koordinacijo sistema zdravstvenega varstva Oddelek za kakovost Štefanova 5 1000 Ljubljana
  • Jana Wahl Klinični center Zaloška 7 1525 Ljubljana
Keywords: clinical pathways, quality, EU, strategic asset planning, health care activity, health care parties

Abstract

Background. The main focus of the survey is on the extent to which clinical pathways are being used, and whether it might provide a basis for improved service planning and consequently strategic asset planning in health care.

Methods. In the first stage, our aim was to make contact with one agency in each country (the primary agency below) that would be able to provide contacts within that country with a mix of experts from each of the following types of agencies: Health sector government regulator, Health care purchasing (insurance) agencies, Senior clinical managers in hospitals, Senior clinical managers in non-hospital care provider agencies (eg, home care, or primary medical care), Health professional societies (preferably medical and nursing), Accreditation or audit agencies, Consumer associations and Public or private agencies concerned with health facilities development. Definitions of these agencies and other terms were attached to the questionnaire itself. We would then ask the primary agency to choose the experts that were most likely to be aware of clinical pathway use. The persons thus contacted would then be asked to complete the questionnaire and send it back to the researchers. The aim was not to attempt to establish a random sample, but rather to target well-informed people.

Results. 51 completed questionnaires were provided by largely self-selected experts from 17 EU countries. Respondents reported that pathways are important and becoming increasingly widely used (although the rate of progress is highly variable), the main constraints to their use are a cultural aversion among doctors and little encouragement from external parties, and there is growing recognition that multi-setting pathways have the greatest potential value.

Conclusions. More needs to be done to achieve a common understanding of the ideas of pathways, strategic asset planning, and the interrelationships. Systems problems need systems solutions. In the case of clinical pathways, this means not only increased education in medical schools. It also means including pathways in licensing and accreditation activities; linking them to product classifications like diagnosis related groups (DRGs); specifying their use in purchaser provider contracts; encouraging health care provider agencies to use pathways as the basis for internal resource allocation; promoting the use of pathways as the framework for improving the quality of health care, internal clinical auditing; running clinical teambuilding workshops; and so on.

Downloads

Download data is not yet available.

References

Byrne D. Interpreting quantitative data. London: SAGE Publications, 2002: 148.

Forkner J. Clinical pathways: benefits and liabilities. Nurs Manage 1996; 27: 35–8.

Woodyard LW. Critical pathway patient outcomes: the missing standard. J Nurs Care Qual 1993; 8: 51–7.

Chang WC, Lin CC. A clinical pathway for laparoscopically assisted vaginal hysterectomy. Impact on costs and clinical outcome. The Journal of Reproductive Medicine 2003; 48: 247–51.

Pace KB, Sakulkoo S, Hoffart N, Cobb AK. Barriers to successful implementation of a clinical pathway for CHF. J Healthc Qual 2002; 24: 32–8.

Kwan-Gett TS, Lozano P, Mullin K, Marcuse EK. One-year experience with an inpatient asthma clinical pathway. Arch Pediatr Adolesc Med 1997; 151: 684–9.

Calligaro KD et al. Impact of clinical pathways on hospital costs and early outcome after major vascular surgery. J Vasc Surg 1994; 22: 649–57; discussion 657–60.

Borkowski V. Implementation of a managed care model in an acute care setting. J Healthc Qual 1994; 16: 25–7, 30.

Kelly CS, Andersen CL, Pestian JP, Wenger AD, Finch AB, Strope GL, Luckstead EF. Improved outcomes for hospitalized asthmatic children using a clinical pathway. Annals of Allergy, Asthma & Immunology 2000; 84: 509–16.

Poole J. Care profiles, pathways and protocols. Physiotherapy 1994; 80: 265–6.

Ireton JC, Orr M, Hennessy K. Clinical pathways in home nutrition support. J Am Diet Assoc 1997: 1003–7.

Santoso U, Iau PT, Lim J, Koh CS, Pang YT. The mastectomy clinical pathway: what has it achieved? Ann Acad Med Singapore 2002; 31: 440–5.

Ransom SB, Studdert DM, Dombrowski MP, Mello MM, Brennan TA. Reduced medicolegal risk by compliance with obstetric clinical pathways: a case-control study. Obstetrics and Gynecology 2003; 101: 751–5.

Willis B, Kim LT, Anthony T, Bergen PC, Nwariaku F, Turnage RH. A clinical pathway for inguinal hernia repair reduces hospital admissions. J Surg Res 2000; 88: 13–7.

Schriefer J, Engelhard J, DiCesare L, Miller M in Schriefer J. Merging clinical pathway programs as part of overall health system mergers: a ten-step guide. Spectrum Health. Jt Comm J Qual Improv 2000; 26: 29–38.

Pischke-Winn K, Wahlfeldt LA, Minnick A. Initiatives to build a competitive healthcare system: integrating service redesign and clinical pathways, Nurs Case Manag 1996; 1: 212–22.

Hindle D. Coming soon to a hospital near you: a commentary on The King Edward Memorial Hospital Inquiry. Australian Health Review 2003; 26: 30– 33.

How to Cite
1.
Hindle D, Yazbeck AM, Wahl J. CLINICAL PATHWAYS IN 17 EUROPEAN UNION COUNTRIES: A SURVEY OF EXPERT OPINIONS. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];73(11). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2379
Section
Quality and safety